Nektar Therapeutics reported $18.85M in Gross Profit on Sales for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
ALKERMES ALKS:US 223.39M 47.4M
Amgen AMGN:US $ 4677M 451M
Astrazeneca AZN:US 9.11B 169M
Baxter International BAX:US $ 1350M 58M
Biocryst Pharmaceuticals BCRX:US $ 49.68M 2.95M
Biogen BIIB:US $ 1777.9M 295.8M
Bristol Myers Squibb BMY:US $ 9177M 452M
Dr.Reddys Laboratories DRRD:IN 35.24B 2.36B
Eisai 4523:JP Y 158750M 35913M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Exelixis EXEL:US $ 342.78M 95.45M
Gilead Sciences GILD:US $ 5166M 549M
GlaxoSmithKline GSK:LN 6.14B 283M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
IONIS PHARMACEUT IONS:US $ 438M 307.99M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
MacroGenics MGNX:US 11.05M 2.15M
Merk MRK:US $ 10567M 873M
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Novartis NOVN:VX 9.52B 3M
Pfizer PFE:US $ 15651M 1516M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Takeda 4502:JP Y 564909M 54981M
Teva Pharmaceutical TEVA:IT 2.12B 227M
YTE INCY:US $ 696.02M 128.26M